The Latest Breaking News from Joseph Kosinski

LOS ANGELES — Daniel Kwan and Daniel Scheinert, the directors of "Everything Everywhere All at Once," were awarded top honors for feature filmmaking by the Directors Guild of America at the 75th DGA Awards, a strong indicator of who could win at the Academy Awards next month.

The Directors Guild of America handed its top prize for feature filmmaking to Daniel Kwan and Daniel Scheinert for “Everything Everywhere All at Once,” putting them on course to win at the Academy Awards next month. The 75th annual DGA Awards, held at the Beverly Hilton in Beverly Hills, California,…

The Directors Guild of America handed its top prize for feature filmmaking to Daniel Kwan and Daniel Scheinert for “Everything Everywhere All at Once,” putting them on course to win at the Academy Awards next month

The Academy rarely rewards crowdpleasing blockbusters. But as prestige dramas bomb at the box office, will it have any other choice?

The belated sequel to Top Gun is easily the highest-grossing film of 2022 – as well as Tom Cruise’s most successful movie ever. Its director explains how hard it was to make the film and why its star never, ever gives up

Tom Cruise put his spin on sci-fi, and the result was better than critics gave it credit for.

Formula 1 team bosses have met with Brad Pitt and legendary producer Jerry Bruckheimer to hear about plans for the forthcoming movie based around the sport.

Formula 1 team bosses have met with Brad Pitt and legendary producer Jerry Bruckheimer to hear about plans for the forthcoming film based around the championship.

Val Kilmer fans, rejoice: Iceman wants to play Batman — again.

“Spiderhead,” now streaming on Netflix for the undemanding, brings up the challenge of stretching a short story into conventional feature film length without the whole thing going sideways.

What do you get by mixing a New Yorker short story, the writers of "Deadpool," the director of "Top Gun: Maverick" and stars Chris Hemsworth and Miles Teller? "Spiderhead" — an intelligent, sometimes moving, sometimes funny sci-fi examination of emotional autonomy amid futuristic pharmaceuticals, until an awkward shift into thriller…